Mair Churchill
Concepts (413)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA | 39 | 2023 | 1460 | 3.070 |
Why?
| | Histones | 14 | 2023 | 641 | 2.400 |
Why?
| | High Mobility Group Proteins | 17 | 2012 | 44 | 2.200 |
Why?
| | DNA-Binding Proteins | 21 | 2019 | 1507 | 1.860 |
Why?
| | Mitochondrial Proteins | 6 | 2019 | 257 | 1.640 |
Why?
| | Bacterial Proteins | 17 | 2018 | 889 | 1.610 |
Why?
| | Transcription Factors | 14 | 2019 | 1717 | 1.420 |
Why?
| | Molecular Chaperones | 9 | 2023 | 196 | 1.310 |
Why?
| | DNA, Mitochondrial | 4 | 2019 | 201 | 1.280 |
Why?
| | Chromatin Assembly Factor-1 | 3 | 2023 | 12 | 1.220 |
Why?
| | Acyl-Butyrolactones | 5 | 2014 | 10 | 1.210 |
Why?
| | Cell Cycle Proteins | 8 | 2014 | 614 | 1.190 |
Why?
| | Ligases | 7 | 2011 | 32 | 1.140 |
Why?
| | Molecular Sequence Data | 42 | 2016 | 2901 | 1.120 |
Why?
| | Histone Chaperones | 3 | 2012 | 16 | 1.110 |
Why?
| | Models, Molecular | 31 | 2015 | 1586 | 1.070 |
Why?
| | Nucleosomes | 7 | 2018 | 156 | 1.010 |
Why?
| | Chromatin Assembly and Disassembly | 3 | 2018 | 106 | 1.010 |
Why?
| | Amino Acid Sequence | 34 | 2016 | 2146 | 0.970 |
Why?
| | Repressor Proteins | 5 | 2018 | 425 | 0.880 |
Why?
| | Quorum Sensing | 7 | 2018 | 78 | 0.860 |
Why?
| | Protein Binding | 24 | 2019 | 2229 | 0.860 |
Why?
| | DNA Damage | 3 | 2023 | 420 | 0.830 |
Why?
| | Saccharomyces cerevisiae Proteins | 6 | 2012 | 404 | 0.750 |
Why?
| | 4-Butyrolactone | 7 | 2012 | 21 | 0.720 |
Why?
| | Pseudomonas aeruginosa | 6 | 2018 | 353 | 0.700 |
Why?
| | Binding Sites | 24 | 2014 | 1310 | 0.700 |
Why?
| | Cytosine | 2 | 2019 | 49 | 0.630 |
Why?
| | Protein Structure, Tertiary | 14 | 2012 | 869 | 0.590 |
Why?
| | CpG Islands | 1 | 2019 | 160 | 0.590 |
Why?
| | Nucleic Acid Conformation | 18 | 2015 | 720 | 0.590 |
Why?
| | Protein Multimerization | 6 | 2019 | 193 | 0.560 |
Why?
| | Base Sequence | 23 | 2012 | 2180 | 0.510 |
Why?
| | Crystallography, X-Ray | 11 | 2015 | 474 | 0.510 |
Why?
| | Transcription, Genetic | 5 | 2019 | 1458 | 0.500 |
Why?
| | Signal Transduction | 9 | 2018 | 5096 | 0.490 |
Why?
| | Drosophila Proteins | 5 | 2014 | 202 | 0.470 |
Why?
| | Sequence Alignment | 9 | 2015 | 345 | 0.450 |
Why?
| | DNA Methylation | 2 | 2019 | 644 | 0.450 |
Why?
| | Gram-Negative Bacteria | 3 | 2010 | 75 | 0.450 |
Why?
| | Promoter Regions, Genetic | 5 | 2019 | 1255 | 0.450 |
Why?
| | Mutation, Missense | 4 | 2017 | 338 | 0.430 |
Why?
| | Receptors, Progesterone | 4 | 2011 | 349 | 0.430 |
Why?
| | Drosophila melanogaster | 11 | 2010 | 228 | 0.420 |
Why?
| | Chromatin | 5 | 2018 | 524 | 0.420 |
Why?
| | Protein Conformation | 12 | 2015 | 930 | 0.410 |
Why?
| | Lipase | 1 | 2013 | 68 | 0.400 |
Why?
| | Site-Specific DNA-Methyltransferase (Adenine-Specific) | 2 | 2003 | 3 | 0.390 |
Why?
| | Mitochondria | 1 | 2019 | 947 | 0.380 |
Why?
| | Insect Proteins | 4 | 2000 | 39 | 0.370 |
Why?
| | Trans-Activators | 6 | 2018 | 399 | 0.370 |
Why?
| | Saccharomyces cerevisiae | 3 | 2012 | 562 | 0.350 |
Why?
| | Sequence Homology, Amino Acid | 9 | 2012 | 387 | 0.350 |
Why?
| | Animals | 45 | 2022 | 37011 | 0.330 |
Why?
| | Crystallization | 7 | 2011 | 144 | 0.330 |
Why?
| | Transcriptional Activation | 2 | 2011 | 379 | 0.320 |
Why?
| | Protein Structure, Secondary | 9 | 2011 | 373 | 0.270 |
Why?
| | Gene Expression Regulation, Bacterial | 6 | 2014 | 328 | 0.260 |
Why?
| | Transferases | 1 | 2006 | 33 | 0.260 |
Why?
| | Mutation | 12 | 2016 | 3964 | 0.260 |
Why?
| | HMG-Box Domains | 3 | 2015 | 3 | 0.260 |
Why?
| | Recombination, Genetic | 3 | 2003 | 198 | 0.260 |
Why?
| | Substrate Specificity | 6 | 2022 | 385 | 0.250 |
Why?
| | HMGB1 Protein | 3 | 2015 | 50 | 0.250 |
Why?
| | Yersinia pestis | 1 | 2006 | 45 | 0.240 |
Why?
| | Adenine | 3 | 2008 | 268 | 0.230 |
Why?
| | Nucleoproteins | 2 | 1994 | 29 | 0.220 |
Why?
| | Endopeptidases | 2 | 2022 | 90 | 0.220 |
Why?
| | Bacteria | 2 | 2011 | 858 | 0.210 |
Why?
| | Porifera | 2 | 2014 | 10 | 0.210 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2023 | 17 | 0.210 |
Why?
| | Gene Silencing | 2 | 2023 | 195 | 0.210 |
Why?
| | Virulence | 3 | 2018 | 266 | 0.200 |
Why?
| | RNA, Ribosomal, 5S | 3 | 1990 | 5 | 0.190 |
Why?
| | Rhenium | 1 | 2001 | 4 | 0.190 |
Why?
| | Pantoea | 1 | 2001 | 2 | 0.190 |
Why?
| | Capsid | 1 | 2022 | 93 | 0.190 |
Why?
| | Bacteriophage lambda | 1 | 2022 | 88 | 0.190 |
Why?
| | Recombinant Proteins | 7 | 2008 | 1357 | 0.180 |
Why?
| | Virus Assembly | 1 | 2022 | 77 | 0.180 |
Why?
| | Capsid Proteins | 1 | 2022 | 94 | 0.180 |
Why?
| | HMGB Proteins | 3 | 2008 | 18 | 0.180 |
Why?
| | Adenosine | 1 | 2003 | 227 | 0.180 |
Why?
| | RNA, Ribosomal | 3 | 1990 | 164 | 0.180 |
Why?
| | Rhodobacter sphaeroides | 1 | 2000 | 7 | 0.180 |
Why?
| | Cyclin A | 2 | 2011 | 17 | 0.170 |
Why?
| | Mammals | 1 | 2022 | 286 | 0.170 |
Why?
| | Structure-Activity Relationship | 4 | 2013 | 586 | 0.170 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2013 | 151 | 0.170 |
Why?
| | Ligands | 2 | 2018 | 665 | 0.170 |
Why?
| | Centrosome | 2 | 2011 | 71 | 0.170 |
Why?
| | DNA, Single-Stranded | 2 | 1991 | 118 | 0.170 |
Why?
| | Archaeal Proteins | 1 | 2000 | 50 | 0.160 |
Why?
| | Burkholderia | 2 | 2009 | 13 | 0.160 |
Why?
| | DNA Repair | 2 | 1991 | 230 | 0.160 |
Why?
| | Xenopus Proteins | 2 | 2012 | 37 | 0.150 |
Why?
| | Oligodeoxyribonucleotides | 3 | 2016 | 143 | 0.150 |
Why?
| | Sea Urchins | 2 | 2016 | 7 | 0.150 |
Why?
| | Humans | 26 | 2019 | 137514 | 0.150 |
Why?
| | Entropy | 2 | 2011 | 41 | 0.140 |
Why?
| | Electrophoretic Mobility Shift Assay | 2 | 2012 | 85 | 0.140 |
Why?
| | Mutagenesis, Site-Directed | 4 | 2016 | 377 | 0.140 |
Why?
| | Gene Deletion | 3 | 2013 | 393 | 0.140 |
Why?
| | Pseudomonas Infections | 2 | 2011 | 224 | 0.140 |
Why?
| | Nuclear Proteins | 3 | 2012 | 710 | 0.130 |
Why?
| | Operon | 2 | 2007 | 65 | 0.130 |
Why?
| | Xenopus | 3 | 2010 | 87 | 0.130 |
Why?
| | Serum Response Factor | 1 | 2016 | 33 | 0.120 |
Why?
| | Deuterium | 2 | 2011 | 98 | 0.120 |
Why?
| | DNA Primers | 3 | 2012 | 514 | 0.120 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2006 | 134 | 0.120 |
Why?
| | Models, Biological | 2 | 2013 | 1775 | 0.120 |
Why?
| | Gene Expression Regulation | 4 | 2016 | 2615 | 0.120 |
Why?
| | Polymerase Chain Reaction | 2 | 1999 | 1061 | 0.120 |
Why?
| | Rhodobacteraceae | 1 | 2014 | 1 | 0.120 |
Why?
| | Hemagglutinins, Viral | 1 | 1994 | 7 | 0.110 |
Why?
| | Sumoylation | 1 | 2014 | 16 | 0.110 |
Why?
| | Protein Interaction Mapping | 2 | 2012 | 109 | 0.110 |
Why?
| | PTEN Phosphohydrolase | 1 | 2016 | 162 | 0.110 |
Why?
| | SUMO-1 Protein | 1 | 2014 | 21 | 0.110 |
Why?
| | Escherichia coli | 4 | 2008 | 815 | 0.110 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2017 | 250 | 0.110 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 1994 | 59 | 0.110 |
Why?
| | Genes, Retinoblastoma | 1 | 1994 | 8 | 0.110 |
Why?
| | Mutant Proteins | 2 | 2013 | 101 | 0.110 |
Why?
| | CREB-Binding Protein | 1 | 2014 | 31 | 0.110 |
Why?
| | Neurodevelopmental Disorders | 1 | 2016 | 179 | 0.110 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2016 | 260 | 0.110 |
Why?
| | Base Composition | 3 | 1990 | 77 | 0.110 |
Why?
| | Chromatography, Liquid | 3 | 2011 | 433 | 0.110 |
Why?
| | Symbiosis | 1 | 2014 | 80 | 0.110 |
Why?
| | Thermodynamics | 4 | 2012 | 421 | 0.110 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2013 | 28 | 0.100 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 1994 | 92 | 0.100 |
Why?
| | Phospholipases | 1 | 2013 | 14 | 0.100 |
Why?
| | Glycolipids | 1 | 2013 | 42 | 0.100 |
Why?
| | Heparan Sulfate Proteoglycans | 1 | 2013 | 26 | 0.100 |
Why?
| | Thymine | 2 | 2008 | 15 | 0.100 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2014 | 211 | 0.100 |
Why?
| | Dendritic Cells | 1 | 2016 | 488 | 0.100 |
Why?
| | Roseobacter | 1 | 2012 | 1 | 0.100 |
Why?
| | Tandem Mass Spectrometry | 3 | 2011 | 533 | 0.100 |
Why?
| | Locomotion | 1 | 2013 | 100 | 0.100 |
Why?
| | Hydrolysis | 1 | 2013 | 191 | 0.100 |
Why?
| | Amino Acid Substitution | 3 | 2012 | 309 | 0.100 |
Why?
| | rho Guanine Nucleotide Dissociation Inhibitor beta | 1 | 2012 | 4 | 0.100 |
Why?
| | DNA, Bacterial | 2 | 2011 | 336 | 0.100 |
Why?
| | Fimbriae Proteins | 2 | 2013 | 20 | 0.100 |
Why?
| | Cholesterol, HDL | 1 | 2013 | 205 | 0.100 |
Why?
| | Protein Kinase C-alpha | 1 | 2012 | 38 | 0.090 |
Why?
| | Crystallography | 2 | 2006 | 27 | 0.090 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2012 | 56 | 0.090 |
Why?
| | Dimerization | 3 | 2006 | 198 | 0.090 |
Why?
| | Immunoglobulin G | 1 | 2016 | 886 | 0.090 |
Why?
| | Response Elements | 2 | 2011 | 91 | 0.090 |
Why?
| | Xenopus laevis | 2 | 2011 | 104 | 0.090 |
Why?
| | Staining and Labeling | 1 | 2012 | 146 | 0.090 |
Why?
| | Ultraviolet Rays | 2 | 1991 | 389 | 0.090 |
Why?
| | Circular Dichroism | 1 | 2011 | 151 | 0.090 |
Why?
| | Markov Chains | 1 | 2011 | 124 | 0.090 |
Why?
| | Hydrogen Bonding | 3 | 2000 | 168 | 0.090 |
Why?
| | Magnetic Resonance Spectroscopy | 5 | 2007 | 619 | 0.090 |
Why?
| | Spectrometry, Fluorescence | 1 | 2012 | 172 | 0.090 |
Why?
| | Enzyme Activation | 1 | 2013 | 816 | 0.090 |
Why?
| | Carbodiimides | 1 | 2011 | 4 | 0.090 |
Why?
| | Cyclin E | 1 | 2011 | 25 | 0.090 |
Why?
| | Genetic Association Studies | 1 | 2013 | 377 | 0.090 |
Why?
| | Catalytic Domain | 2 | 2003 | 227 | 0.090 |
Why?
| | Protein Stability | 1 | 2011 | 178 | 0.090 |
Why?
| | Cholesterol | 1 | 2013 | 413 | 0.090 |
Why?
| | Cell Survival | 2 | 1991 | 1122 | 0.090 |
Why?
| | Genes | 2 | 1990 | 230 | 0.090 |
Why?
| | Metalloproteins | 1 | 1990 | 6 | 0.090 |
Why?
| | B-Lymphocytes | 1 | 2016 | 847 | 0.090 |
Why?
| | Hydroxides | 5 | 1990 | 26 | 0.090 |
Why?
| | DNA, Ribosomal | 1 | 1990 | 86 | 0.080 |
Why?
| | Antibodies, Viral | 1 | 1994 | 623 | 0.080 |
Why?
| | Immunity, Innate | 1 | 2016 | 832 | 0.080 |
Why?
| | Myocytes, Cardiac | 1 | 2014 | 528 | 0.080 |
Why?
| | Models, Genetic | 2 | 1994 | 607 | 0.080 |
Why?
| | Alleles | 1 | 2013 | 891 | 0.080 |
Why?
| | Protein Processing, Post-Translational | 1 | 2012 | 471 | 0.080 |
Why?
| | Chemoreceptor Cells | 1 | 2010 | 54 | 0.080 |
Why?
| | Biofilms | 1 | 2012 | 262 | 0.080 |
Why?
| | Bayes Theorem | 1 | 2011 | 407 | 0.080 |
Why?
| | Nasal Mucosa | 1 | 2010 | 109 | 0.080 |
Why?
| | Light | 1 | 1991 | 383 | 0.070 |
Why?
| | Burkholderia mallei | 1 | 2008 | 7 | 0.070 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2016 | 177 | 0.070 |
Why?
| | Peptide Fragments | 2 | 2007 | 708 | 0.070 |
Why?
| | Amino Acid Motifs | 2 | 2011 | 225 | 0.070 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2010 | 222 | 0.070 |
Why?
| | Genotype | 1 | 2013 | 1920 | 0.070 |
Why?
| | Pseudomonas | 1 | 2007 | 31 | 0.070 |
Why?
| | Static Electricity | 3 | 2004 | 120 | 0.070 |
Why?
| | Taste | 1 | 2010 | 234 | 0.070 |
Why?
| | Fimbriae, Bacterial | 1 | 2007 | 32 | 0.070 |
Why?
| | Free Radicals | 5 | 1990 | 109 | 0.070 |
Why?
| | Vaccines, Synthetic | 1 | 2007 | 126 | 0.070 |
Why?
| | Adenocarcinoma | 1 | 1994 | 937 | 0.070 |
Why?
| | Cell Cycle | 1 | 2010 | 604 | 0.070 |
Why?
| | Cricetinae | 3 | 2011 | 288 | 0.070 |
Why?
| | Hydroxyl Radical | 4 | 1990 | 92 | 0.060 |
Why?
| | Proteins | 2 | 1995 | 1012 | 0.060 |
Why?
| | Alanine | 1 | 2006 | 153 | 0.060 |
Why?
| | Acetylation | 3 | 2014 | 254 | 0.060 |
Why?
| | Receptors, Cell Surface | 1 | 2007 | 391 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2193 | 0.060 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 3 | 2009 | 340 | 0.060 |
Why?
| | Gene Expression Regulation, Fungal | 2 | 2012 | 73 | 0.060 |
Why?
| | Molecular Structure | 2 | 2007 | 508 | 0.060 |
Why?
| | Acyl Carrier Protein | 1 | 2004 | 9 | 0.060 |
Why?
| | Kinetics | 3 | 2004 | 1679 | 0.060 |
Why?
| | Nucleic Acid Heteroduplexes | 2 | 1997 | 8 | 0.050 |
Why?
| | Phosphorylation | 3 | 2013 | 1762 | 0.050 |
Why?
| | Microtubule-Associated Proteins | 1 | 2005 | 197 | 0.050 |
Why?
| | Crossing Over, Genetic | 1 | 2003 | 3 | 0.050 |
Why?
| | Amino Acids | 2 | 2005 | 503 | 0.050 |
Why?
| | Chlorine | 1 | 2003 | 61 | 0.050 |
Why?
| | Phosphoproteins | 1 | 2005 | 338 | 0.050 |
Why?
| | Colorado | 1 | 2013 | 4521 | 0.050 |
Why?
| | Serogroup | 1 | 2022 | 44 | 0.050 |
Why?
| | HMGB2 Protein | 1 | 2002 | 5 | 0.050 |
Why?
| | Neoplasm Proteins | 1 | 2005 | 433 | 0.050 |
Why?
| | DNA Mutational Analysis | 2 | 2016 | 401 | 0.050 |
Why?
| | Inflammation | 1 | 2013 | 2837 | 0.050 |
Why?
| | Proteolysis | 1 | 2022 | 180 | 0.050 |
Why?
| | Models, Chemical | 1 | 2003 | 268 | 0.050 |
Why?
| | CHO Cells | 2 | 2011 | 161 | 0.040 |
Why?
| | DNA-Cytosine Methylases | 1 | 2000 | 3 | 0.040 |
Why?
| | Receptors, Estrogen | 1 | 2004 | 435 | 0.040 |
Why?
| | Cricetulus | 2 | 2011 | 110 | 0.040 |
Why?
| | Protein Folding | 1 | 2022 | 282 | 0.040 |
Why?
| | Lung Neoplasms | 1 | 1994 | 2494 | 0.040 |
Why?
| | HEK293 Cells | 2 | 2014 | 734 | 0.040 |
Why?
| | S-Adenosylmethionine | 1 | 2000 | 54 | 0.040 |
Why?
| | Nitrogen Isotopes | 1 | 2000 | 72 | 0.040 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 220 | 0.040 |
Why?
| | Disulfides | 2 | 1997 | 107 | 0.040 |
Why?
| | Nucleotides | 1 | 2000 | 125 | 0.040 |
Why?
| | Carbon Isotopes | 1 | 2000 | 145 | 0.040 |
Why?
| | Catalysis | 1 | 2000 | 319 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2016 | 2501 | 0.040 |
Why?
| | Mice | 6 | 2016 | 17843 | 0.040 |
Why?
| | Chromatography, Ion Exchange | 1 | 1999 | 54 | 0.040 |
Why?
| | Mice, Inbred BALB C | 2 | 2009 | 1271 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2009 | 1800 | 0.040 |
Why?
| | Cell Line | 3 | 2010 | 2852 | 0.040 |
Why?
| | COS Cells | 2 | 2009 | 188 | 0.040 |
Why?
| | Chromosomes | 1 | 1999 | 108 | 0.040 |
Why?
| | Cytochromes c | 1 | 1998 | 60 | 0.040 |
Why?
| | Electrophoresis | 1 | 1997 | 33 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 1999 | 536 | 0.040 |
Why?
| | Mice, Transgenic | 2 | 2016 | 2182 | 0.040 |
Why?
| | Fungal Proteins | 1 | 1998 | 134 | 0.030 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 1998 | 130 | 0.030 |
Why?
| | Muscidae | 1 | 1996 | 1 | 0.030 |
Why?
| | DNA Nucleotidyltransferases | 1 | 1996 | 11 | 0.030 |
Why?
| | Ataxia | 1 | 2016 | 45 | 0.030 |
Why?
| | Methionine | 1 | 1997 | 159 | 0.030 |
Why?
| | Rats | 2 | 2016 | 5676 | 0.030 |
Why?
| | Strabismus | 1 | 2016 | 29 | 0.030 |
Why?
| | Fluorescence | 2 | 2010 | 161 | 0.030 |
Why?
| | Water | 1 | 2000 | 464 | 0.030 |
Why?
| | Transfection | 2 | 2012 | 948 | 0.030 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 3 | 2010 | 346 | 0.030 |
Why?
| | Syndrome | 1 | 2016 | 359 | 0.030 |
Why?
| | Protein Kinases | 1 | 1998 | 319 | 0.030 |
Why?
| | United Kingdom | 1 | 2016 | 324 | 0.030 |
Why?
| | DNA Transposable Elements | 1 | 1996 | 122 | 0.030 |
Why?
| | Fushi Tarazu Transcription Factors | 1 | 1995 | 5 | 0.030 |
Why?
| | Canada | 1 | 2016 | 421 | 0.030 |
Why?
| | Face | 1 | 2016 | 175 | 0.030 |
Why?
| | Age of Onset | 1 | 2016 | 522 | 0.030 |
Why?
| | Gene Order | 1 | 2014 | 26 | 0.030 |
Why?
| | Intellectual Disability | 1 | 2016 | 165 | 0.030 |
Why?
| | Binding, Competitive | 1 | 1995 | 211 | 0.030 |
Why?
| | Adjuvants, Immunologic | 1 | 2016 | 226 | 0.030 |
Why?
| | Binding Sites, Antibody | 1 | 1994 | 42 | 0.030 |
Why?
| | Antibody Formation | 1 | 2016 | 299 | 0.030 |
Why?
| | Antigen-Antibody Reactions | 1 | 1994 | 55 | 0.030 |
Why?
| | Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1994 | 25 | 0.030 |
Why?
| | Biocatalysis | 1 | 2014 | 69 | 0.030 |
Why?
| | Neutrons | 1 | 1994 | 10 | 0.030 |
Why?
| | Plasmids | 2 | 2004 | 363 | 0.030 |
Why?
| | Tyrosine | 1 | 1995 | 224 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 3 | 2004 | 665 | 0.030 |
Why?
| | Molecular Weight | 3 | 2005 | 332 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 1997 | 741 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 1994 | 137 | 0.030 |
Why?
| | Protein Biosynthesis | 2 | 2014 | 434 | 0.030 |
Why?
| | Developmental Disabilities | 1 | 2016 | 266 | 0.030 |
Why?
| | Inverted Repeat Sequences | 1 | 2013 | 20 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 1997 | 1059 | 0.030 |
Why?
| | Transcription Factor TFIIIA | 2 | 1990 | 5 | 0.030 |
Why?
| | Methods | 2 | 1990 | 65 | 0.030 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2016 | 446 | 0.030 |
Why?
| | Genetic Loci | 1 | 2014 | 288 | 0.030 |
Why?
| | Checkpoint Kinase 2 | 1 | 2012 | 29 | 0.030 |
Why?
| | Conserved Sequence | 2 | 2007 | 239 | 0.030 |
Why?
| | Histone Deacetylases | 1 | 2014 | 215 | 0.020 |
Why?
| | Drosophila | 1 | 2014 | 146 | 0.020 |
Why?
| | Epitopes | 1 | 1994 | 481 | 0.020 |
Why?
| | HeLa Cells | 1 | 2014 | 640 | 0.020 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2012 | 151 | 0.020 |
Why?
| | Lysine | 1 | 2014 | 297 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2014 | 845 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 1994 | 849 | 0.020 |
Why?
| | Point Mutation | 1 | 2012 | 234 | 0.020 |
Why?
| | Serine | 1 | 2012 | 141 | 0.020 |
Why?
| | Netropsin | 1 | 1991 | 1 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 1995 | 504 | 0.020 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 1991 | 141 | 0.020 |
Why?
| | Temperature | 2 | 2004 | 680 | 0.020 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2011 | 39 | 0.020 |
Why?
| | G1 Phase | 1 | 2011 | 71 | 0.020 |
Why?
| | S Phase | 1 | 2011 | 78 | 0.020 |
Why?
| | Distamycins | 1 | 1990 | 1 | 0.020 |
Why?
| | Models, Structural | 1 | 1990 | 40 | 0.020 |
Why?
| | Molecular Conformation | 1 | 1991 | 152 | 0.020 |
Why?
| | Dactinomycin | 1 | 1990 | 28 | 0.020 |
Why?
| | Edetic Acid | 1 | 1990 | 50 | 0.020 |
Why?
| | Heterotrimeric GTP-Binding Proteins | 1 | 2010 | 14 | 0.020 |
Why?
| | X-Ray Diffraction | 1 | 1990 | 104 | 0.020 |
Why?
| | Guanine | 1 | 1990 | 79 | 0.020 |
Why?
| | Trigeminal Nerve | 1 | 2010 | 29 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2010 | 75 | 0.020 |
Why?
| | Quaternary Ammonium Compounds | 1 | 2010 | 53 | 0.020 |
Why?
| | Burkholderia Infections | 1 | 2009 | 4 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2010 | 155 | 0.020 |
Why?
| | Leucine Zippers | 1 | 2009 | 17 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3420 | 0.020 |
Why?
| | Fibroblasts | 1 | 2014 | 990 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2009 | 126 | 0.020 |
Why?
| | Ovary | 1 | 1991 | 218 | 0.020 |
Why?
| | Spermatozoa | 1 | 1989 | 94 | 0.020 |
Why?
| | TRPM Cation Channels | 1 | 2010 | 82 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 3020 | 0.020 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2010 | 132 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2009 | 183 | 0.020 |
Why?
| | Hydroxylation | 1 | 1988 | 42 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2010 | 402 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2016 | 4206 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2016 | 1979 | 0.020 |
Why?
| | Chromatography, Thin Layer | 1 | 2007 | 23 | 0.020 |
Why?
| | Phenazines | 1 | 2007 | 11 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2007 | 155 | 0.020 |
Why?
| | Deoxyribonuclease I | 3 | 1995 | 39 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 1994 | 1428 | 0.020 |
Why?
| | Blotting, Western | 1 | 2010 | 1227 | 0.020 |
Why?
| | Zinc | 1 | 1990 | 298 | 0.020 |
Why?
| | Antigens, Bacterial | 1 | 2007 | 129 | 0.020 |
Why?
| | DNA Footprinting | 2 | 1996 | 33 | 0.020 |
Why?
| | Ultracentrifugation | 1 | 2005 | 52 | 0.020 |
Why?
| | Chromatography, Gel | 1 | 2005 | 127 | 0.020 |
Why?
| | Aurora Kinase B | 1 | 2005 | 8 | 0.020 |
Why?
| | Aurora Kinases | 1 | 2005 | 27 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2010 | 1740 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2016 | 6059 | 0.010 |
Why?
| | Immunization | 1 | 2007 | 414 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2007 | 812 | 0.010 |
Why?
| | Male | 4 | 2016 | 67718 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2004 | 227 | 0.010 |
Why?
| | Zinc Fingers | 1 | 2004 | 50 | 0.010 |
Why?
| | Estrogen Receptor beta | 1 | 2004 | 39 | 0.010 |
Why?
| | Glutathione Transferase | 1 | 2004 | 104 | 0.010 |
Why?
| | Calcium | 1 | 2010 | 1233 | 0.010 |
Why?
| | Calorimetry | 1 | 2003 | 69 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2005 | 595 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 1994 | 5792 | 0.010 |
Why?
| | Survival Rate | 1 | 2007 | 1980 | 0.010 |
Why?
| | Infant | 1 | 2016 | 9467 | 0.010 |
Why?
| | Estrogen Receptor alpha | 1 | 2004 | 144 | 0.010 |
Why?
| | Peptides | 1 | 2008 | 986 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 2066 | 0.010 |
Why?
| | Female | 4 | 2016 | 73162 | 0.010 |
Why?
| | Hydro-Lyases | 1 | 1998 | 4 | 0.010 |
Why?
| | Sex-Determining Region Y Protein | 1 | 1998 | 2 | 0.010 |
Why?
| | Lymphoid Enhancer-Binding Factor 1 | 1 | 1998 | 6 | 0.010 |
Why?
| | Precipitin Tests | 1 | 1998 | 100 | 0.010 |
Why?
| | Cytochrome c Group | 1 | 1998 | 43 | 0.010 |
Why?
| | Acetyltransferases | 1 | 1998 | 22 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 1998 | 78 | 0.010 |
Why?
| | Yeasts | 1 | 1998 | 54 | 0.010 |
Why?
| | DNA Restriction Enzymes | 2 | 1988 | 52 | 0.010 |
Why?
| | Histone Acetyltransferases | 1 | 1998 | 61 | 0.010 |
Why?
| | Adolescent | 1 | 2016 | 21555 | 0.010 |
Why?
| | Manganese Compounds | 1 | 1996 | 2 | 0.010 |
Why?
| | Transposases | 1 | 1996 | 20 | 0.010 |
Why?
| | Child | 1 | 2016 | 22037 | 0.010 |
Why?
| | Chlorides | 1 | 1996 | 140 | 0.010 |
Why?
| | Cross-Linking Reagents | 1 | 1995 | 212 | 0.010 |
Why?
| | Oligonucleotides | 1 | 1995 | 149 | 0.010 |
Why?
| | Solutions | 1 | 1994 | 170 | 0.010 |
Why?
| | RNA, Messenger | 2 | 1993 | 2838 | 0.010 |
Why?
| | Larva | 1 | 1993 | 221 | 0.010 |
Why?
| | Software | 1 | 1998 | 670 | 0.010 |
Why?
| | Phylogeny | 1 | 1996 | 898 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 1993 | 523 | 0.010 |
Why?
| | Diethyl Pyrocarbonate | 1 | 1990 | 2 | 0.010 |
Why?
| | Electrophoresis, Agar Gel | 1 | 1990 | 26 | 0.010 |
Why?
| | Endonucleases | 1 | 1990 | 32 | 0.010 |
Why?
| | Magnesium | 1 | 1990 | 159 | 0.010 |
Why?
| | Copper | 1 | 1990 | 109 | 0.010 |
Why?
| | Computer Simulation | 1 | 1994 | 986 | 0.010 |
Why?
| | Purines | 1 | 1990 | 176 | 0.010 |
Why?
| | Nucleotide Mapping | 1 | 1988 | 3 | 0.000 |
Why?
| | Iron | 1 | 1990 | 313 | 0.000 |
Why?
| | Chromosome Deletion | 1 | 1988 | 115 | 0.000 |
Why?
| | Oocytes | 1 | 1988 | 176 | 0.000 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 1987 | 28 | 0.000 |
Why?
| | Indicators and Reagents | 1 | 1987 | 109 | 0.000 |
Why?
| | Viral Proteins | 1 | 1987 | 346 | 0.000 |
Why?
|
|
Churchill's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|